Advertisement
Screener

HARVARD BIOSCIENCE, INC. (HBIO) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

HARVARD BIOSCIENCE INC Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2026-06-30 was 131.46%, a 92.35% decline year-over-year.
  • HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2026-03-31 was 162.58%, a 88.65% decline year-over-year.
  • HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2025-12-31 was 1747.30%, a 452.29% increase year-over-year.
  • HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2025-09-30 was 1487.98%, a 344.06% increase year-over-year.
  • HARVARD BIOSCIENCE INC return tang equity for fiscal 2025 was 1747.30%, a 452.29% increase from fiscal 2024.
  • HARVARD BIOSCIENCE INC return tang equity for fiscal 2024 was 316.37%, a change of 2213.60% from fiscal 2023.
  • HARVARD BIOSCIENCE INC return tang equity for fiscal 2023 was -1897.22%, a 1062.97% decline from fiscal 2022.
  • HARVARD BIOSCIENCE INC return tang equity for fiscal 2022 was 197.02%, a 881.67% increase from fiscal 2021.
Available history
2009-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30131.46%-$10.41M-$7.92M
2026-03-31162.58%-$9.78M-$6.02M
2025-12-311747.30%-$56.7M-$3.25M
2025-09-301487.98%-$53.84M-$3.62M
2025-06-301718.74%-$57.41M-$3.34M
2025-03-311432.30%-$58.05M-$4.05M
2024-12-31316.37%-$12.41M-$3.92M
2024-09-30335.08%-$14.24M-$4.25M
2024-06-30407.40%-$10.68M-$2.62M
2024-03-31369.18%-$8.73M-$2.37M
2023-12-31-1897.22%-$3.42M$180,000.00
2023-09-30-280.09%-$3.26M$1.17M
2023-06-30-1172.57%-$5.43M$463,000.00
2023-03-31117.30%-$2.01M-$1.72M
2022-12-31197.02%-$9.52M-$4.83M
2022-09-30134.31%-$6.89M-$5.13M
2022-06-30134.09%-$3.65M-$2.73M
2022-03-3198.10%-$6.5M-$6.63M
2021-12-3120.07%-$288,000.00-$1.44M
2021-09-3019.02%-$1.86M-$9.8M
2021-06-3027.96%-$2.79M-$9.99M
2021-03-3131.09%-$3.96M-$12.75M
2020-12-3152.75%-$7.81M-$14.81M
2020-09-3045.67%-$6.65M-$14.55M
2020-06-3050.57%-$8.17M-$16.15M
2020-03-3137.85%-$6.83M-$18.05M
2019-12-3136.17%-$4.69M-$12.96M
2019-09-3013.11%-$2.38M-$18.11M
2019-06-300.06%-$11,000.00-$17.58M
2019-03-316.13%-$1.23M-$20.02M
2018-12-3115.29%-$2.92M-$19.11M
2018-09-3022.84%-$4.79M-$20.95M
2018-06-3018.92%-$4.95M-$26.15M
2018-03-3114.68%-$3.86M-$26.32M
2017-12-31-2.50%-$865,000.00$34.53M
2017-09-30-15.51%-$3.18M$20.53M
2017-06-30-23.10%-$4.41M$19.07M
2017-03-31-27.47%-$4.74M$17.25M
2016-12-31-25.80%-$4.31M$16.69M
2016-09-30-115.63%-$20.13M$17.41M
2016-06-30-111.70%-$19.34M$17.31M
2016-03-31-106.29%-$18.27M$17.19M
2015-12-31-116.31%-$19.04M$16.37M
2015-09-30-6.07%-$1.92M$31.62M
2015-06-30-1.40%-$438,000.00$31.19M
2015-03-310.86%$235,000.00$27.25M
2014-12-316.83%$2.36M$34.49M
2014-09-303.67%$1.62M$44.15M
2014-06-300.00%$2,000.00$43.71M
2014-03-31-2.93%-$1.21M$41.13M
2013-12-31-4.71%-$1.83M$38.87M
2013-09-300.25%$129,000.00$52.17M
2013-06-301.95%$979,000.00$50.11M
2013-03-314.00%$1.94M$48.46M
2012-12-315.07%$2.37M$46.79M
2012-09-304.48%$1.91M$42.61M
2012-06-305.15%$2.07M$40.17M
2012-03-316.92%$2.67M$38.49M
2011-12-319.79%$3.81M$38.92M
2011-09-3013.77%$5.26M$38.19M
2011-06-3042.88%$17.96M$41.88M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-311747.30%-$56.7M-$3.25M
2024-12-31316.37%-$12.41M-$3.92M
2023-12-31-1897.22%-$3.42M$180,000.00
2022-12-31197.02%-$9.52M-$4.83M
2021-12-3120.07%-$288,000.00-$1.44M
2020-12-3152.75%-$7.81M-$14.81M
2019-12-3136.17%-$4.69M-$12.96M
2018-12-3115.29%-$2.92M-$19.11M
2017-12-31-2.50%-$865,000.00$34.53M
2016-12-31-25.80%-$4.31M$16.69M
2015-12-31-116.31%-$19.04M$16.37M
2014-12-316.83%$2.36M$34.49M
2013-12-31-4.71%-$1.83M$38.87M
2012-12-315.07%$2.37M$46.79M
2011-12-319.79%$3.81M$38.92M
2010-12-3154.45%$19.02M$34.92M
2009-12-319.61%$7.23M$75.26M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Precipio, Inc. (PRPO)United States$0.043B-36.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15